DEZLUMIA

Serial Number 97002052
734

Registration Progress

Application Filed
Aug 30, 2021
Under Examination
Mar 8, 2022
Approved for Publication
Jan 11, 2022
Published for Opposition
Jan 11, 2022
Registered

Trademark Image

DEZLUMIA

Basic Information

Serial Number
97002052
Filing Date
August 30, 2021
Published for Opposition
January 11, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Jul 23, 2024
Application
Pending
Classes
005

Rights Holder

Biohaven Therapeutics Ltd.

99
Address
Ritter House, P.O. Box 173
Road Town, Tortola VG1110
VG

Ownership History

Biohaven Therapeutics Ltd.

Original Applicant
99
New Haven, CT

Biohaven Therapeutics Ltd.

Owner at Publication
99
Road Town, Tortola VG

Legal Representation

Attorney
Monica Riva Talley

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

31 events
Date Code Type Description Documents
Jul 24, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 23, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Jul 23, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jul 23, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jan 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jan 25, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jan 25, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 28, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 26, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 26, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 26, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 17, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Apr 17, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Apr 17, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 25, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Feb 23, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Feb 23, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Feb 23, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 10, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Sep 8, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Sep 8, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Sep 8, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 8, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 11, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 11, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 22, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 7, 2021 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 6, 2021 DOCK D ASSIGNED TO EXAMINER Loading...
Oct 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Sep 2, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection

Classification

International Classes
005